First study of omicron shows Pfizer vaccine may be less effective

The omicron variant of the coronavirus partially evades antibody immunity from two doses of the Pfizer-BioNTech vaccine, according to initial data from South Africa published Tuesday.The small study of 12 patients conducted by the Africa Health…